Interferon and ribavirin therapy in dialysis patients with chronic hepatitis C

被引:19
作者
Bruchfeld, A [1 ]
Ståhle, L
Andersson, J
Schvarcz, R
机构
[1] Karolinska Inst, Div Renal Med, Stockholm, Sweden
[2] Karolinska Inst, Div Clin Pharmacol, Stockholm, Sweden
[3] Karolinska Inst, Div Infect Dis, Stockholm, Sweden
[4] Huddinge Univ Hosp, Stockholm, Sweden
关键词
D O I
10.1093/ndt/16.8.1729
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:1729 / 1729
页数:1
相关论文
共 3 条
  • [1] BRUCHFELD A, IN PRESS J VIRAL HEP
  • [2] Determination of ribavirin in serum using highly selective solid-phase extraction and high-performance liquid chromatography
    Svensson, JO
    Bruchfeld, A
    Schvarcz, R
    Ståhle, L
    [J]. THERAPEUTIC DRUG MONITORING, 2000, 22 (02) : 215 - 218
  • [3] Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study
    Tan, ACITL
    Brouwer, JT
    Glue, P
    van Leusen, R
    Kauffmann, RH
    Schalm, SW
    de Vries, RA
    Vroom, B
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (01) : 193 - 195